Epidemiology of Vitiligo – A Dual Population-Based Approach
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Most epidemiological data on vitiligo refer to selected environments or focus on the prevalence of comorbidity unrelated to the population. OBJECTIVE: Aim of the study was to gain robust representative prevalence data on vitiligo and on associated dermatologic comorbidity in the German adult population. METHODS: A dual population-based approach was applied with 1) primary data obtained between 2004 and 2014 from dermatological exams in the general working population; 2) claims data from a large German statutory health insurance, reference year 2010. RESULTS: In the working cohort (N = 121,783; 57% male; mean age 43 years), the prevalence of vitiligo was 0.77% (0.84% in men; 0.67% in women). In the claims data (N = 1,619,678; 38% male; mean age 46 years), prevalence was 0.17% (0.14% in men; 0.18% in women). In the working cohort, vitiligo was significantly more common in people with fair skin type, ephelides and port-wine stains and less common in people with acne and solar lentigines. In the claims data, vitiligo was associated with a variety of skin conditions, eg, atopic dermatitis, psoriasis and alopecia areata. CONCLUSION: The resulting discrepancy of claims vs primary data between 0.17% and 0.77% indicates the most probable spectrum of vitiligo prevalence in Germany. It is more frequently observed in clinical exams than recorded in claims data, indicating a marked proportion of people seeking no medical help. Such nonattendance may result from the fact that many treatment options do not provide satisfying benefits to the patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As not all patients with vitiligo seek medical attention or treatment, the actual prevalence in the UK population may be higher than observed in this dataset.4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of diagnosed vitiligo in the UK reported here falls within European estimates obtained from surveys or medical screenings, and is comparable to recent UK estimates (approximately 0.3%) representing the prevalence of diagnosed vitiligo in patients registered with a GP.3,4,10”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Data on the incidence of vitiligo are scarce; in Europe, the prevalence rate of diagnosed vitiligo ranges from 0.2% to 0.8%, with geographical and methodological differences. 1,3,4”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Comorbidities in patients with vitiligo in our study were most often higher than those reported in individuals without vitiligo from other studies (Figure 4).4,8,10,[17][18][19][20]”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germany: Health System Review.
Blümel, M., Spranger, A., Achstetter, K., Maresso, A., & Busse, R. (2014) · PubMed · Cited by 625
A review of the worldwide prevalence of vitiligo in children/adolescents and adults
Krüger, C., & Schallreuter, K. U. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05377.x · Cited by 571
New discoveries in the pathogenesis and classification of vitiligo
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.048 · Cited by 476
Mohan, G. C., & Silverberg, J. I. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3324 · Cited by 209
Ständer, S., Schäfer, I., Phan, N. Q., Blome, C., Herberger, K., Heigel, H., & Augustin, M. (2010) · Dermatology · doi:10.1159/000319862 · Cited by 206
Self-citationPrevalence of skin lesions and need for treatment in a cohort of 90 880 workers
Augustin, M., Herberger, K., Hintzen, S., Heigel, H., Franzke, N., & Schäfer, I. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10436.x · Cited by 194
Self-citationWillingness-to-pay and quality of life in patients with vitiligo
Radtke, M. A., Schäfer, I., Gajur, A., Langenbruch, A., & Augustin, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09091.x · Cited by 178
Self-citationPrevalence of Skin Diseases in a Cohort of 48,665 Employees in Germany
Schaefer, I., Rustenbach, S. J., Zimmer, L., & Augustin, M. (2008) · Dermatology · doi:10.1159/000136656 · Cited by 178
Self-citationParadisi, A., Tabolli, S., Didona, B., Sobrino, L., Russo, N., & ABENI, D. D. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.07.050 · Cited by 156
Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
Elbuluk, N., & Ezzedine, K. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.002 · Cited by 149
Research works printed but not linked: 2
- Al-Harbi, 2013, Skinmed, 11, 327
- Busse, 2014, Health Syst Transit, 16, 224
Cited by
Vitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
Bibeau, K., Pandya, A. G., Ezzedine, K., Jones, H., Gao, J., Lindley, A., & Harris, J. E. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18257 · Cited by 137
Vitiligo: A Review of Aetiology, Pathogenesis, Treatment, and Psychosocial Impact
AL-Smadi, K., Imran, M., Leite‐Silva, V. R., & Mohammed, Y. (2023) · Cosmetics · doi:10.3390/cosmetics10030084 · Cited by 94
Ezzedine, K., Sénéschal, J., Silva, A. D., Préaubert, N., Lamblin, A., Delattre, C., Emery, C., Nevoret, C., Finzi, J., Bouée, S., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19447 · Cited by 41
Haulrig, M. B., Al-Sofi, R. F., Baskaran, S., Siewertsen, M., Løvendorf, M. B., Dyring‐Andersen, B., Skov, L., & Loft, N. (2024) · JEADV Clinical Practice · doi:10.1002/jvc2.526 · Cited by 43
Salama, A. H., Alnemr, L., Khan, A. R., Alfakeer, H., Aleem, Z., & Ali-Alkhateeb, M. (2023) · Cureus · doi:10.7759/cureus.45030 · Cited by 51
Metadata
- Authors
- Mohr, N., Petersen, J., Kirsten, N., & Augustin, M.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Mohr, Nicole
- Petersen, Jana
- Kirsten, Natalia
- Augustin, Matthias
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2021-05
- Volume
- Volume 13
- Pages
- 373-382
- ISSN
- 1179-1349 (ISSN-L)
- PMC
- PMC8165096
- OpenAlex
- W3165836662
- Cited by
- 41
- References
- 32
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 16 · 2023: 8 · 2022: 2 · 2021: 3
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Epidemiology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- vitiligo, prevalence, atopic dermatitis, psoriasis, alopecia areata, skin type, port-wine stain, freckles, liver spots, acne, underdiagnosis, health insurance claims data, working population, German adults
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
